A Case of Photodynamic Therapy of Juxtafoveal Choroidal Neovascularization in Angioid Streaks.
10.3341/jkos.2008.49.4.685
- Author:
Yeon Jeong PARK
1
;
Eurie KIM
;
In Young CHUNG
;
Jong Moon PARK
Author Information
1. Department of Ophthalmology Gyeong Sang National University, Colleage of Medicine, Gyeongnam, Korea. in0@netian.com
- Publication Type:Case Report
- Keywords:
Angioid streaks;
Juxtafoveal choroidal neovascularization;
Verteporfin photodynamic therapy
- MeSH:
Angioid Streaks;
Choroid;
Choroidal Neovascularization;
Eye;
Follow-Up Studies;
Humans;
Male;
Middle Aged;
Photochemotherapy;
Porphyrins;
Tomography, Optical Coherence;
Triazenes;
Vision Disorders;
Visual Acuity
- From:Journal of the Korean Ophthalmological Society
2008;49(4):685-690
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To report a case of verteporfin photodynamic therapy (PDT) for juxtafoveal choroidal neovascularization (CNV) secondary to angioid streaks. CASE SUMMARY: An 54-year-old male presented with metamorphopsia of the right eye. It was diagnosed as juxtafoveal CNV secondary to angioid streaks and treated with verteporfin PDT-Best corrected visual acuity (BCVA) and macular thickness by optical coherence tomography (OCT) were measured. Over 14 month follow-up period, baseline BCVA was 0.3 and it increased to 0.4 by the final examination, while macular thickness decreased from 264 micrometer to 229 micrometer. No side effects of PDT were noted. CONCLUSIONS: Verteporfin PDT for CNV-associated with angioid streaks does not appear to significantly alter the course of the disease undergoing enlargement and disciform transformation of the neovascular process. However, we expected that the actual clinical findings improved during short term follow-up. The severity of symptoms of CNV-associated with angioid streaks in a single patient varies over time, so long-term follow-up and careful examination is needed.
